Thursday, August 20, 2020 6:12:01 PM
As far as psychedelics in general are concerned, a normal person can setup their own personal psilocybe cubensis grow system for less than 100$ that will produce endlessly with minimal effort. Therefore I don't believe that psychedelics will be a huge revenue potential for any company, at best if medical legalization ever happens, shrooms will show up in already functioning cannabis dispensaries for people too busy or too lazy to just grow their own. that plus the fact that they are not habit forming, and in fact help people overcome their bad habits, adds to not such a lucrative situation for businesses.
So to sum it up, any company pr distributed by this "company" or any other that has them claiming to be on the forefront of psychedelic research, is more than likely just another buzzword capitalization marketing scam, designed to pull in investment funding dollars, and deliver nothing but business losses and reduced share values in return.
Be very careful investing in otc stocks I'm sure 99% of the otc stocks are just scams that do exactly this situation (deplete the auth, r/s, change names and start over). As far as doing good DD, make sure that any company you invest into has an actual product that you would be interested in buying. The people who do the paperwork can make the financials look however they want them to look, and can keep current even if the "company" is circling the drain. If you decide to jump in on any otc stock, wait for a significant drop, and be ready to short, same day or within that week... longs in the otc market always lose...
best of luck.... TranscendSelf~
Recent PSYC News
- PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures • InvestorsHub NewsWire • 03/13/2024 11:13:44 AM
- PSYC's CEO Provides Detailed Update on the State of the Company in Newly Released Podcast Recording • InvestorsHub NewsWire • 01/05/2024 01:30:00 PM
- PSYC's CEO to Moderate Panel at The Cannabis & Psychedelics Investment Summit Hosted by Kahner Global • InvestorsHub NewsWire • 11/08/2023 01:30:00 PM
- PSYC's Psychedelic Spotlight to be Media Partner for 2023 reMind Psychedelic Business Forum • InvestorsHub NewsWire • 10/04/2023 12:30:00 PM
- Multi Media Company Announces Acquisition • AllPennyStocks.com • 09/21/2023 02:45:00 PM
- PSYC Acquires Stock Day Media to Help Bolster Revenue Production Capacity • InvestorsHub NewsWire • 08/31/2023 12:30:00 PM
- PSYC Enters Strategic Partnership with Target Media to Help Accelerate Audience and Revenue Growth Opportunities • InvestorsHub NewsWire • 08/29/2023 12:30:00 PM
- PSYC's Psychedelic Spotlight Continues Ascent as a Top-Ranking Multimedia Platform for the Psychedelics Sector • InvestorsHub NewsWire • 06/06/2023 12:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM